Logo for SpectraCure

SpectraCure Investor Relations Material

Latest events

Logo for SpectraCure

Q2 2024

15 Aug, 2024
Logo for SpectraCure

Q1 2024

16 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from SpectraCure

Access all reports
SpectraCure AB is a medical technology company that focuses on developing innovative cancer treatment systems. The company's primary technology involves interstitial photodynamic therapy (PDT), which uses laser light and photo-reactive drugs to treat solid cancer tumors. SpectraCure's proprietary system aims to provide a minimally invasive and highly precise treatment option, particularly for recurrent prostate cancer. The technology is designed to improve the quality of life for patients by targeting and eliminating deep-seated tumors. SpectraCure was founded in 2003 and is headquartered in Lund, Sweden. Its shares are listed on the Nasdaq Stockholm.